Experimental Virus-Targeting drugs tested for deadly rare disorder
NCT ID NCT00092222
Summary
This study aims to understand and treat a rare, often fatal disorder called KSHV-associated multicentric Castleman's disease, which is caused by a virus and linked to certain cancers. Researchers are testing several experimental drug combinations in 75 adult participants to see if they can better control the disease. The study also tracks the natural course of the illness to learn how it progresses and causes symptoms.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Conditions
Explore the condition pages connected to this study.